fig2
![Nanocarrier drugs in the treatment of brain tumors](https://image.oaes.cc/4b673a06-495d-4cba-88bb-aa412a706fec/1793.fig.2.png)
Figure 2. Cytotoxic effect of doxorubicin loaded apoferritin with and without targeting antibody anti-GCPII (PSMA) on its surface and free doxorubicin on (A) prostatic cancer cell line (LNCaP) expressing PSMA and (B) human umbilical vein endothelial cells (HUVEC)